Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.

OBJECTIVES This report addressed the question 'What is the clinical and cost-effectiveness of spinal cord stimulation (SCS) in the management of chronic neuropathic or ischaemic pain?' DATA SOURCES Thirteen electronic databases [including MEDLINE (1950-2007), EMBASE (1980-2007) and the Cochrane Library (1991-2007)] were searched from inception; relevant journals were hand-searched; and appropriate websites for specific conditions causing chronic neuropathic/ischaemic pain were browsed. Literature searches were conducted from August 2007 to September 2007. REVIEW METHODS A systematic review of the literature sought clinical and cost-effectiveness data for SCS in adults with chronic neuropathic or ischaemic pain with inadequate response to medical or surgical treatment other than SCS. Economic analyses were performed to model the cost-effectiveness and cost-utility of SCS in patients with neuropathic or ischaemic pain. RESULTS From approximately 6000 citations identified, 11 randomised controlled trials (RCTs) were included in the clinical effectiveness review: three of neuropathic pain and eight of ischaemic pain. Trials were available for the neuropathic conditions failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS) type I, and they suggested that SCS was more effective than conventional medical management (CMM) or reoperation in reducing pain. The ischaemic pain trials had small sample sizes, meaning that most may not have been adequately powered to detect clinically meaningful differences. Trial evidence failed to demonstrate that pain relief in critical limb ischaemia (CLI) was better for SCS than for CMM; however, it suggested that SCS was effective in delaying refractory angina pain onset during exercise at short-term follow-up, although not more so than coronary artery bypass grafting (CABG) for those patients eligible for that surgery. The results for the neuropathic pain model suggested that the cost-effectiveness estimates for SCS in patients with FBSS who had inadequate responses to medical or surgical treatment were below 20,000 pounds per quality-adjusted life-year (QALY) gained. In patients with CRPS who had had an inadequate response to medical treatment the incremental cost-effectiveness ratio (ICER) was 25,095 pounds per QALY gained. When the SCS device costs varied from 5000 pounds to 15,000 pounds, the ICERs ranged from 2563 pounds per QALY to 22,356 pounds per QALY for FBSS when compared with CMM and from 2283 pounds per QALY to 19,624 pounds per QALY for FBSS compared with reoperation. For CRPS the ICERs ranged from 9374 pounds per QALY to 66,646 pounds per QALY. If device longevity (1 to 14 years) and device average price (5000 pounds to 15,000 pounds) were varied simultaneously, ICERs were below or very close to 30,000 pounds per QALY when device longevity was 3 years and below or very close to 20,000 pounds per QALY when device longevity was 4 years. Sensitivity analyses were performed varying the costs of CMM, device longevity and average device cost, showing that ICERs for CRPS were higher. In the ischaemic model, it was difficult to determine whether SCS represented value for money when there was insufficient evidence to demonstrate its comparative efficacy. The threshold analysis suggested that the most favourable economic profiles for treatment with SCS were when compared to CABG in patients eligible for percutaneous coronary intervention (PCI), and in patients eligible for CABG and PCI. In these two cases, SCS dominated (it cost less and accrued more survival benefits) over CABG. CONCLUSIONS The evidence suggested that SCS was effective in reducing the chronic neuropathic pain of FBSS and CRPS type I. For ischaemic pain, there may need to be selection criteria developed for CLI, and SCS may have clinical benefit for refractory angina short-term. Further trials of other types of neuropathic pain or subgroups of ischaemic pain, may be useful.

[1]  H. Vermeulen,et al.  Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. , 2013, The Cochrane database of systematic reviews.

[2]  Y. Jeon,et al.  Spinal cord stimulation for chronic pain. , 2009, Annals of the Academy of Medicine, Singapore.

[3]  R. Deyo,et al.  Authors’ reply to the letter to the Editor by Richard North and Jane Shipley regarding the editorial, ‘Spinal cord stimulation: Stimulating questions,’ Pain 2007;132:10–11 , 2008, PAIN®.

[4]  B. Meyerson,et al.  Baclofen‐enhanced spinal cord stimulation and intrathecal baclofen alone for neuropathic pain: Long‐term outcome of a pilot study , 2008, European journal of pain.

[5]  William E. Fehrenbach,et al.  Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain. , 2007, Pain medicine.

[6]  G. Milbouw,et al.  Spinal cord stimulation vs conventional medical management: a multicenter randomized controlled trial of patients with failed back surgery syndrome (PROCESS study) , 2007 .

[7]  H Hemingway,et al.  Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study , 2007, BMJ : British Medical Journal.

[8]  G. Baumann,et al.  Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study , 2007, Heart.

[9]  J. Brazier,et al.  A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis , 2006, BMJ : British Medical Journal.

[10]  Krishna Kumar,et al.  Complications of spinal cord stimulation, suggestions to improve outcome, and financial impact. , 2006, Journal of neurosurgery. Spine.

[11]  M. van Kleef,et al.  Spinal cord stimulation for chronic reflex sympathetic dystrophy--five-year follow-up. , 2006, The New England journal of medicine.

[12]  Hester Vermeulen,et al.  Spinal cord stimulation for critical leg ischemia: a review of effectiveness and optimal patient selection. , 2006, Journal of pain and symptom management.

[13]  Krishna Kumar,et al.  Spinal Cord Stimulation in Treatment of Chronic Benign Pain: Challenges in Treatment Planning and Present Status, a 22-Year Experience , 2006, Neurosurgery.

[14]  E. Buchser,et al.  Spinal cord stimulation for complex regional pain syndrome: A systematic review of the clinical and cost‐effectiveness literature and assessment of prognostic factors , 2006, European journal of pain.

[15]  E. Buchser,et al.  Spinal Cord Stimulation for Chronic Back and Leg Pain and Failed Back Surgery Syndrome: A Systematic Review and Analysis of Prognostic Factors , 2005, Spine.

[16]  G. Spincemaille,et al.  Systematic review and meta‐analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia , 2004, The British journal of surgery.

[17]  R. Deyo,et al.  Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications , 2004, Pain.

[18]  R. Cork,et al.  A Comparison Of The Verbal Rating Scale And The Visual Analog Scale For Pain Assessment , 2003 .

[19]  Srinivasa N. Raja,et al.  Spinal Cord Stimulation for Complex Regional Pain Syndrome: An Evidence-Based Medicine Review of the Literature , 2003, The Clinical journal of pain.

[20]  D. Ubbink,et al.  Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[21]  Krishna Kumar,et al.  Treatment of Chronic Pain with Spinal Cord Stimulation versus Alternative Therapies: Cost-effectiveness Analysis , 2002, Neurosurgery.

[22]  R. Gepstein,et al.  Surgical treatment of painful spasticity after spinal cord injury , 2002, Spinal Cord.

[23]  M. Pasic,et al.  The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. , 2002, European heart journal.

[24]  A. Nordwall,et al.  2001 Volvo Award Winner in Clinical Studies: Lumbar Fusion Versus Nonsurgical Treatment for Chronic Low Back Pain: A Multicenter Randomized Controlled Trial From the Swedish Lumbar Spine Study Group , 2001, Spine.

[25]  A. Raviele,et al.  Long-term effects of spinal cord stimulation on myocardial ischemia and heart rate variability: results of a 48-hour ambulatory electrocardiographic monitoring. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[26]  J. Habbema,et al.  Technical Data and Complications of Spinal Cord Stimulation: Data from a Randomized Trial on Critical Limb Ischemia , 2000, Stereotactic and Functional Neurosurgery.

[27]  C. Mannheimer,et al.  Effects of Spinal Cord Stimulation and Coronary Artery Bypass Grafting on Myocardial Ischemia and Heart Rate Variability: Further Results from the ESBY Study , 2000, Cardiology.

[28]  H. D. de Vet,et al.  An objective and standardized test of foot function: normative values and validation in patients with reflex sympathetic dystrophy. , 2000, Archives of physical medicine and rehabilitation.

[29]  H C de Vet,et al.  Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. , 2000, The New England journal of medicine.

[30]  J. Beard ABC of arterial and venous disease: Chronic lower limb ischaemia. , 2000, BMJ.

[31]  J. Habbema,et al.  Spinal cord stimulation in patients with critical limb ischemia: A preliminary evaluation of a multicentre trial , 2000, Acta Chirurgica Austriaca.

[32]  J. Brouwer,et al.  Clinical Follow‐up After Cessation of Chronic Electrical Neuromodulation in Patients with Severe Coronary Artery Disease: A Prospective Randomized Controlled Study on Putative Involvement of Sympathetic Activity , 1999, Pacing and clinical electrophysiology : PACE.

[33]  J. Habbema,et al.  Spinal-cord stimulation in critical limb ischaemia: a randomised trial , 1999, The Lancet.

[34]  M. Staal,et al.  Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. , 1998, American heart journal.

[35]  A D Oxman,et al.  The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials , 1998, BMJ.

[36]  C. Blomstrand,et al.  Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. , 1998, Circulation.

[37]  H. Breivik Chronic pain and the sympathetic nervous system , 1997, Acta anaesthesiologica Scandinavica. Supplementum.

[38]  S. Tesfaye,et al.  Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy , 1996, The Lancet.

[39]  S. Horsch,et al.  Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. , 1996, International angiology : a journal of the International Union of Angiology.

[40]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[41]  J. Turner,et al.  Spinal cord stimulation for chronic low back pain: a systematic literature synthesis. , 1995, Neurosurgery.

[42]  P. Marquis,et al.  Clinical validation of a quality of life questionnaire in angina pectoris patients. , 1995, European heart journal.

[43]  E. Steyerberg,et al.  Design issues of a randomised controlled clinical trial on spinal cord stimulation in critical limb ischaemia. ESES Study Group. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[44]  L. Augustinsson,et al.  Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[45]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[46]  R A Deyo,et al.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. , 1995, Journal of the American College of Cardiology.

[47]  L. D. de Witte,et al.  The sickness impact profile: SIP68, a short generic version. First evaluation of the reliability and reproducibility. , 1994, Journal of clinical epidemiology.

[48]  R A Deyo,et al.  The importance of placebo effects in pain treatment and research. , 1994, JAMA.

[49]  L. D. de Witte,et al.  The development of a short generic version of the Sickness Impact Profile. , 1994, Journal of clinical epidemiology.

[50]  L. Augustinsson,et al.  Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. , 1993, BMJ.

[51]  J. Passchier,et al.  The Dutch Version of the Nottingham Health Profile: Investigations of Psychometric Aspects , 1993, Psychological reports.

[52]  R. Harden,et al.  Chronic‐Pain Medications: Equivalence Levels and Method of Quantifying Usage , 1992, The Clinical journal of pain.

[53]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[54]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[55]  R. Fitzpatrick,et al.  Measurement of health status in patients with chronic illness: comparison of the Nottingham health profile and the general health questionnaire. , 1990, Family practice.

[56]  S P McKenna,et al.  Measuring health status: a new tool for clinicians and epidemiologists. , 1985, The Journal of the Royal College of General Practitioners.

[57]  S P McKenna,et al.  The Nottingham Health Profile: subjective health status and medical consultations. , 1981, Social science & medicine. Part A, Medical sociology.

[58]  R. Melzack Prolonged relief of pain by brief, intense transcutaneous somatic stimulation , 1975, PAIN.

[59]  R. Melzack The McGill Pain Questionnaire: Major properties and scoring methods , 1975, PAIN.

[60]  R. H. Jebsen,et al.  An objective and standardized test of hand function. , 1969, Archives of physical medicine and rehabilitation.

[61]  J. Habbema,et al.  Spinal cord stimulation is not cost-effective for non-surgical management of critical limb ischaemia. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[62]  S. Piantadosi,et al.  Spinal cord stimulation versus reoperation for failed back surgery syndrome: a prospective, randomized study design. , 1995, Acta neurochirurgica. Supplement.

[63]  R. North,et al.  A prospective, randomized study of spinal cord stimulation versus reoperation for failed back surgery syndrome: initial results. , 1994, Stereotactic and functional neurosurgery.

[64]  M. Staal,et al.  Preliminary results of a randomized study on the clinical efficacy of spinal cord stimulation for refractory severe angina pectoris. , 1993, Acta neurochirurgica. Supplementum.

[65]  L. Leape,et al.  Coronary Angiography: A Literature Review and Ratings of Appropriateness and Necessity , 1992 .

[66]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[67]  A. Williams EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[68]  A. Kasuya EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[69]  M. Argyle,et al.  The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. , 1988, Social science & medicine.